Stay updated on TATE-PD1 Combo in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the TATE-PD1 Combo in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TATE-PD1 Combo in Liver Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No other visible content changes are indicated.
    Difference
    0.1%
    Check dated 2026-04-16T10:15:35.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Added 'Hepatocellular carcinoma' as a disease term on the page. Updated the page revision to v3.5.0 (replacing v3.4.3).
    Difference
    0.1%
    Check dated 2026-03-18T15:45:18.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:52:03.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Gastric cancer added as a condition for the study. Resources section now includes a link to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-02-18T03:06:21.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is displayed. The prior government-funding operating-status notice has been removed; core study details remain unchanged.
    Difference
    0.4%
    Check dated 2026-02-11T01:58:06.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    A site-wide funding/status notice was added and the site version updated to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-03T23:20:14.000Z thumbnail image

Stay in the know with updates to TATE-PD1 Combo in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TATE-PD1 Combo in Liver Cancer Clinical Trial page.